# Intrathecal Versus Intravenous Dexmeditomedine in Transurethral Resection of the Prostate

> **NCT04618965** · PHASE4 · UNKNOWN · sponsor: **Tanta University** · enrollment: 75 (estimated)

## Conditions studied

- Dexmedetomidine
- Transurethral Resection of Prostate
- Intravenous
- Intrathecal

## Interventions

- **DRUG:** control group
- **DRUG:** Intrathecal dexmedetomidine
- **DRUG:** Intravenous dexmedetomidine

## Key facts

- **NCT ID:** NCT04618965
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-01
- **Primary completion:** 2021-04-26
- **Final completion:** 2021-06-26
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2020-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04618965

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04618965, "Intrathecal Versus Intravenous Dexmeditomedine in Transurethral Resection of the Prostate". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04618965. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*